Publications by authors named "Pierre Labauge"

Claim this Profile
D
Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis.
Alexandra Garcia, Stephane Rodriguez, Emilie Dugast, Christine Lebrun-Frenay, Eric Thouvenot, Pierre Labauge

Ann Clin Transl Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Antoine Gavoille, Fabien Rollot, Romain Casey, Guillaume Mathey, Emmanuelle Le Page, Pierre Labauge

JAMA Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.
Sarah Wilson, Emmanuelle Leray, Floriane Calocer, Fabien Rollot, Mathieu Fauvernier, Pierre Labauge

BMC Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis.
Isabel Charlotte Hostettler, Ana Ponciano, Duncan Wilson, Gareth Ambler, Aneesh B Singhal, Pierre M Labauge

Neurology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.
Antoine Gavoille, Mikail Nourredine, Fabien Rollot, Romain Casey, Guillaume Mathey, Pierre Labauge

J Neurol Neurosurg Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TWEAK and TNFɑ Pro-inflammatory Soluble Cytokines and their Specific Autoantibodies Secretion in Multiple Sclerosis Patients.
Sylvie Carmona, Jehanne Aghzadi, Thierry Vincent, Pierre Labauge, Clarisse Carra-Dallière

Inflammation· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.
Camille Robin, Fabien Rollot, Mathilde Lefort, Romain Casey, Sandra Vukusic, Pierre M Labauge

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
Antoine Gavoille, Emmanuelle Leray, Romain Marignier, Fabien Rollot, Romain Casey, Pierre Labauge

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network.
Johannes Lorscheider, Alessio Signori, Suvitha Subramaniam, Pascal Benkert, Sandra Vukusic, Pierre Labauge

J Neurol Neurosurg Psychiatry· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal Brain MRI in Anti-NMDA Receptor Encephalitis: Clinical and Prognostic Implications.
Laura Khatib, Julie Pique, Nicolas Lundahl Ciano-Petersen, Guillaume Criton, Cristina Birzu, Pierre M Labauge

Neurol Neuroimmunol Neuroinflamm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study.
Mikael Cohen, Fabien Rollot, Marc Debouverie, Hélène Zephir, Sandra Vukusic, Pierre Labauge

Eur J Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France.
Jérôme de Sèze, Pierre Labauge, Roland Liblau, Mikel Martinez, Thibault Moreau

Adv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited added value of systematic spinal cord MRI vs brain MRI alone to classify patients with MS as active or inactive during follow-up.
Jérémy Hong, Malo Gaubert, Mathilde Lefort, Jean Christophe Ferré, Emmanuelle Le Page, Pierre Labauge

J Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.
Marie Mainguy, Romain Casey, Sandra Vukusic, Christine Lebrun-Frenay, Eric Berger, Pierre M Labauge

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population.
Elisabeth Maillart, Fabien Rollot, Emmanuelle Leray, Lakhdar Benyahya, Bertrand Bourre, Pierre Labauge

Mult Scler· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?
Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, Xavier Ayrignac, Patrick Vermersch, Pierre Labauge

Mult Scler J Exp Transl Clin· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TEC-ADHERE: Real-World Persistence and Adherence on Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis in the French OroSEP Patient-Support Program.
Pierre Labauge, Alain Créange, Thibault Moreau, Jocelyne Nouvet-Gire, Bernard Pedespan

Neurol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between education level and disability progression in patients with multiple sclerosis in France.
Mathilde Lefort, Olivier Dejardin, Eric Berger, Jean-Philippe Camdessanché, Jonathan Ciron, Pierre Labauge

Mult Scler· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France.
Mathilde Lefort, Olivier Dejardin, Eric Berger, Jean-Philippe Camdessanché, Jonathan Ciron, Pierre Labauge

Mult Scler· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study.
Marion Hay, Fabien Rollot, Romain Casey, Anne Kerbrat, Gilles Edan, Pierre Labauge

Neurology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up.
Xavier Ayrignac, Safa Aouinti, Thierry Vincent, Clarisse Carra-Dallière, Mahmoud Charif, Pierre Labauge

Mult Scler Relat Disord· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome.
Cassandre Landes-Château, Vito Ag Ricigliano, Lydiane Mondot, Eric Thouvenot, Pierre Labauge

Mult Scler· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
Antoine Gavoille, Fabien Rollot, Romain Casey, Anne Kerbrat, Emmanuelle Le Page, Pierre Labauge

JAMA Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations.
Annabelle Chaussenot, Xavier Ayrignac, Nicolas Chatron, Terry Granchon-Riolzir, Pierre Labauge

Eur J Hum Genet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study.
Lou Grangeon, Grégoire Boulouis, Jean Capron, Fouzi Bala, Dimitri Renard, Pierre M Labauge

Neurology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis